Published in Bone Marrow Transplant on June 01, 1997
Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol (2006) 0.96
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature (1990) 4.62
Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant (2008) 2.86
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood (2001) 2.15
Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med (2010) 2.13
A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat Med (2001) 2.09
Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol (2000) 2.05
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05
Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant (2011) 1.96
Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother (1998) 1.82
First evidence of pep solar neutrinos by direct detection in Borexino. Phys Rev Lett (2012) 1.77
Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant (2000) 1.75
Interferon production by human and murine lymphocytes in response to alloantigens. J Immunol (1980) 1.70
Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med (2001) 1.63
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia (2005) 1.63
Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci U S A (2001) 1.62
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant (2004) 1.55
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med (2001) 1.51
Evaluation of the control of Myobia musculi infestations on laboratory mice with permethrin. Lab Anim Sci (1986) 1.47
Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med (1998) 1.47
Experimental hamster enteritis: an electron microscopic study. Am J Vet Res (1977) 1.43
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant (1999) 1.41
Autogenous transplantation of impacted maxillary canines. Oral Surg Oral Med Oral Pathol (1989) 1.39
Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood (1997) 1.35
Umbilical cord blood transplantation. Transfusion (1995) 1.32
Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant (2011) 1.26
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother (2008) 1.26
Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant (2007) 1.23
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant (2009) 1.21
Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity. J Exp Med (1985) 1.19
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant (2001) 1.18
Proliferative ileitis of hamsters: electron microscopy of bacteria in cells. Am J Vet Res (1973) 1.16
A fatal cytauxzoonosis-like disease in cats. J Am Vet Med Assoc (1976) 1.13
Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma (2005) 1.10
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis. Leukemia (2004) 1.10
Precision measurement of the (7)Be solar neutrino interaction rate in Borexino. Phys Rev Lett (2011) 1.09
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation. Bone Marrow Transplant (2010) 1.09
New semisolid agar for the detection of motile salmonellae. J Clin Microbiol (1988) 1.08
Usefulness of breast self-examination for an early detection of breast cancer results of a study on 500 breast cancer patients and 652 controls. Tumori (1981) 1.08
Hexamitiasis in laboratory mice, hamsters, and rats. Lab Anim Sci (1974) 1.07
Immunochemistry of the cell-wall carbohydrate of group L hemolytic streptococci. J Immunol (1971) 1.06
Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood (1987) 1.06
Stem cell migration and proliferation during severe anemia. Blood (1970) 1.05
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts. Leukemia (2003) 1.05
Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr (2010) 1.03
Campylobacter fetus subspecies jejuni isolated from Syrian hamsters with proliferative ileitis. Lab Anim Sci (1982) 1.03
Isolation of Actinobacillus lignieresii and Actinobacillus equuli from laboratory rodents. J Clin Microbiol (1980) 1.02
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors. Bone Marrow Transplant (2011) 1.02
Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol (2000) 1.01
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol (1998) 1.00
Antimicrobial evaluation of coumarins and flavonoids from the stems of Daphne gnidium L. Phytomedicine (2001) 1.00
Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival. Bone Marrow Transplant (2008) 0.98
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia (2005) 0.98
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood (2000) 0.98
Cell therapy: achievements and perspectives. Haematologica (1999) 0.98
Incidence of cardiac and other soft tissue mineralized lesions in DNA-2 mice. Lab Anim Sci (1972) 0.98
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis. Transpl Infect Dis (2015) 0.96
AURA: Atlas of UTR Regulatory Activity. Bioinformatics (2011) 0.96
Naltrexone-induced dysphoria in former opioid addicts. Am J Psychiatry (1985) 0.96
Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr (2009) 0.96
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia (2010) 0.95
Bone marrow transplantation without myeloablation for sickle cell disease. N Engl J Med (2001) 0.94
Therapy of molecular relapse in acute promyelocytic leukemia. Blood (1999) 0.94
Effect of shipping stress on clincopathologic indicators in F344/N rats. Am J Vet Res (1987) 0.94
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. J Clin Oncol (1988) 0.93
Electron microscopy of intestinal epithelial cells of piglets infected with a transmissible gastroenteritis virus. Can J Comp Med (1973) 0.92
Epizootic fatal dermatitis in athymic nude mice due to Staphylococcus xylosus. Lab Anim Sci (1993) 0.92
Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer. Anticancer Res (2001) 0.91
Protective action of a new benzofuran derivative on lipid peroxidation and sulphydryl groups oxidation. Pharmacol Res (1991) 0.91
A method for the removal of endotoxin from purified colony-stimulating factor. Proc Soc Exp Biol Med (1980) 0.91
Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion (1995) 0.90
Detection of Salmonella infections by polyvalent enzyme-linked immunosorbent assay. J Clin Microbiol (1981) 0.89
Hemodynamic instability after extracranial carotid stenting. Acta Neurochir (Wien) (2006) 0.89
APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage. Neurology (2005) 0.89
Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol (1991) 0.89
Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet Gynecol (2001) 0.89
Counterflow centrifugal elutriation: present and future. Bone Marrow Transplant (1993) 0.88
Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. Gene Ther (2010) 0.88
CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF. Bone Marrow Transplant (1998) 0.88
Implementation of a semiclosed large scale counterflow centrifugal elutriation system. J Clin Apher (1987) 0.88
Unrelated donor bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant (1996) 0.87
Physiologic distribution of colony-stimulating factor in vivo. Blood (1979) 0.87
Haemopoietic cell transplantation in children with juvenile myelomonocytic leukaemia. Br J Haematol (1998) 0.87
P. aeruginosa bloodstream infections among hematological patients: an old or new question? Ann Hematol (2012) 0.87
Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders. Leukemia (2004) 0.86
Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant (2001) 0.86